MIBR beat Lynn Vision 2-0 at IEM Cologne
MIBR beat Lynn Vision 2-0 at IEM Cologne. Felipe “insani” Yuji went 41-16 with a 2.21 rating and Klimentii “kl1m” Krivosheev’s solo B 4K sealed the win and advanced MIBR to Stage 2.
MIBR defeated Lynn Vision 2-0 during Stage 1 of the IEM Cologne Major in Germany, winning on Anubis and Inferno to secure a place in Stage 2.
On Anubis Lynn Vision ran slow, spread-out default plays early in the match. MIBR adapted after several rounds and won a majority of positional fights and trades. Felipe “insani” Yuji finished 41-16 with a 2.21 rating, a 140.7 average damage per round and a 90.9% KAST.
On Inferno MIBR established control from the start. When Lynn Vision applied economic pressure, Klimentii “kl1m” Krivosheev held B alone in a three-versus-five and recorded a four-kill round that ended Lynn Vision’s recovery efforts.
Other MIBR statistics: Linus “LNZ” Holtäng went 28-15 with a 1.44 rating; Klimentii “kl1m” was 33-9 with a 1.44 rating; Breno “brnz4n” Polettobio was 22-18 with a 1.18 rating; Carlos “venomzera” Eduardo was 19-14 with a 1.08 rating. For Lynn Vision, Lizhi “Starry” Ye led with 23-26 and a 1.00 rating; the other starters recorded ratings below 0.70.
MIBR opened Stage 1 with a loss to THUNDER dOWNUNDER and then recorded narrow wins over TYLOO and Team Liquid before facing Lynn Vision. The 2-0 result completed MIBR’s Stage 1 slate and advanced them to Stage 2; Lynn Vision is eliminated from the tournament.
IEM Cologne continues as a Major event in the Counter-Strike calendar, with teams competing for Major points and prize money.
The content on news.white.market is provided for informational purposes only and should not be considered financial, investment, trading, legal, or tax advice. We strive to keep our news accurate and up to date, but we cannot guarantee its completeness, reliability, or absolute accuracy.
news.white.market is not responsible for any errors, omissions, or losses resulting from reliance on this content. Any actions you take based on our materials are done at your own risk. Always conduct your own research and consult a qualified specialist where necessary.








